Press Releases

CD BioSciences Unveiled WMicroTrackers, Powered by Non-invasive Tracking Technology

Baylor Genetics to Share Scientific and Clinical Insights on AI, Precision Diagnostics, Carrier Screening and More in 11 Presentations at ACMG 2024

– Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, will showcase its latest advancements and research discoveries at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting on March 12-16 in Toronto, Canada.

DIASORIN RECEIVES FDA 510(K) CLEARANCE FOR ITS LIAISON PLEX® SYSTEM, THE NEW MULTIPLEXING PLATFORM OF THE GROUP, TOGETHER WITH THE LIAISON PLEX® RESPIRATORY PANEL

Diasorin has received 510(k) clearance from the U.S. FDA for the company’s new LIAISON PLEX® platform as well as its first panel of tests, the LIAISON PLEX® Respiratory Flex Assay.

LIQUID STABLE AND NIST VERIFIED CLINICAL REFERENCE MATERIALS FOR LITHIUM AVAILABLE FROM VERICHEM

VERICHEM LABORATORIES now offers two, distinct multi-level test kits of clinical reference materials for the calibration verification of Lithium assays.

Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services

Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics

PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseases

New collaboration will enhance ability to identify those more at risk of developing brain diseases to enable earlier interventions

Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics

Pioneering Human Whole Genome PacBio SMRT Sequencing with CD Genomics

Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data

Paving the way to advance cancer research and diagnosis with enriched, high-quality DICOM images

Unraveling the Genomic Mysteries with CD Genomics’ RIP-Seq Services

Driving Genomic Research Forward with Advanced CRISPR Sequencing by CD Genomics

PathAI Launches New Pathologist-Centric Features on AISight to Enable Efficient Case Review through Intelligent Case Prioritization and Real-Time Multi-Institutional Collaboration

PathAI, Inc., a leading AI-powered precision pathology company, today announced the availability of two new features on the AISight digital pathology image management system – an Intelligent Caselist and AISight Live.

Backed by Leading Health Systems, Vale Health Launches at Vive 2024; Wellness Marketplace Platform Enables Self-Directed Access to Vetted Products

AVIA’s Generative AI Strategic Collaborative Highlights Six-Month Milestones And Outlines Next Steps For Pioneering Initiative

Creative Enzymes Proudly Unveils Its Cutting-Edge Product, Recombinant Human Hyaluronidase PH20

Creative Enzymes Rolls out Customized Solutions in Enzyme, Probiotic and Extract Blends

Huateng Pharma Introduces Semaglutide Side Chain

Huateng Pharma, a leading provider of high-quality pharmaceutical intermediates, is proud to unveil its latest breakthrough product: Semaglutide Side Chain. This innovative addition to Huateng Pharma's portfolio represents a significant milestone in pharmaceutical innovation, offering a range of compounds including AEEA-AEEA (CAS NO.: 1143516-05-5), SNAC (CAS NO.: 203787-91-1), tBuO-Ste-Glu(AEEA-AEEA)-OtBu (CAS NO.:1118767-16-0), and Fmoc-L-Lys[Oct-(otBu)-Glu-(otBu)-AEEA-AEEA]-OH (CAS NO.: 1662688-20-1).

Creative Proteomics Unveils Comprehensive Exosome Lipidomics Services

Creative Proteomics Enhances Research Capabilities with Urine Untargeted Metabolomics